The new platform technology modeled after the brain is composed of a tangled-up network of wires containing silver, laid on a bed of electrodes. Credit: Sam Lilak/UCLA…
Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate dendritic cells -- which play a key role in immune response -- that eradicated tumors and prevented their recurrence in…
Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease, according to trial data presented at a medical meeting on Monday.…
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest…
Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand.Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk's high-dose experimental obesity pill…
Pavlo Gonchar | Lightrocket | Getty ImagesPfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical…
Breadcrumb Trail Links PMN Business Author of the article: The Associated Press Kirsten Grieshaber Published Jun 10, 2023 • 5 minute read Article content FUERTH, Germany (AP) — The artificial intelligence…
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal…